4 Item 1A. Risk Factors 40 Item 1B. Unresolved Staff Comments 88 Item 1C. Cybersecurity 88 Item 2. Properties 89 Item 3. Legal Proceedings 89 Item 4. Mine Safety Disclosures 90 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 91 Item 6. [Reserved] 91 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 92 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 102 Item ...
Q2 FY2026 — expected 2026-08-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001193125-26-097543 | EDGAR | 95K words |
| 2025-03-27 | 2024-12-31 | 0000950170-25-045725 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001193125-25-265714 | EDGAR | 31K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-102391 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0000950170-25-067496 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123291 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095421 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058188 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-09 | 0001193125-26-097535 | EDGAR | 2K words |
| 2025-11-05 | 0001193125-25-265707 | EDGAR | — |
| 2025-08-05 | 0000950170-25-102386 | EDGAR | — |
| 2025-06-23 | 0000950170-25-089002 | EDGAR | — |
| 2025-05-23 | 0000950170-25-076911 | EDGAR | — |
| 2025-05-09 | 0000950170-25-067495 | EDGAR | — |
| 2025-04-01 | 0001193125-25-070496 | EDGAR | — |
| 2025-03-27 | 0000950170-25-045722 | EDGAR | — |
| 2024-12-12 | 0000950170-24-135768 | EDGAR | — |
| 2024-11-07 | 0000950170-24-123274 | EDGAR | — |
27 total filings indexed. 9 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001782303 |
| Ticker | BOLD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.boundlessbio.com |
| Listed | 2024-03-28 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report